x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DAA-001212
| Product Information | |
|---|---|
| Product Name | Porcine Insulin ELISA Kit |
| Species | Human; Mouse; Rat; Cow; Pig |
| Description | Porcine Insulin ELISA Kit is an in-vitro enzyme-linked immunosorbent assay for the quantitative measurement of Porcine Insulin in serum (Porcine Insulin concentration is low in normal serum/plasma and may not be detectable in this assay), plasma and cell culture supernatants. This assay employs an antibody specific for porcine Insulin coated on a 96- well plate. Standards and samples are pipetted into the wells and Insulin present in a sample is bound to the wells by the immobilized antibody. The wells are washed, and biotinylated anti- Porcine Insulin antibody is added. After washing away unbound biotinylated antibody, HRP-conjugated streptavidin is pipetted to the wells. The wells are again washed, a TMB substrate solution is added to the wells and color develops in proportion to the amount of Insulin bound. |
| Sample Types | Cell Culture Supernatant, Serum, Plasma |
| Detection Range | 4.69 µlU/mL - 300 µlU/mL |
| Sensitivity | 4 µlU/mL |
| Target Information | |
|---|---|
| Target Name | INS |
| UniProt No. | P01308 |
| Gene ID | 3630 |
| Target Description | Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. |
| Alternative Names | IDDM; IDDM1; IDDM2; ILPR; ins; INS_HUMAN; Insulin A chain; Insulin B chain; IRDN; MODY10; Preproinsulin; Proinsulin; Proinsulin precursor |
| Shipping & Storage | |
|---|---|
| Sipping | Shipping on dry ice. |
| Storage | Store at -20°C. Please refer to protocols. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
